Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
ASCO 9:785, 1990
Epidemiology of prostate cancer
(2021) identified various active components in HQD for liver fibrosis using a pharmacokinetics-based strategy, which was validated in the CCl4-induced mouse liver fibrosis model
BPC-157/TB-500 Blend (e.g., 5 mg BPC-157 + 5 mg TB-500 per vial) BPC-157 5mgTB-500 5mg Combo Chemical Components: BPC-157: Body Protection Compound-157 (pentadecapeptide) TB-500: Thymosin Beta-4 fragment (synthetic peptide fragment) Molecular Formula: BPC-157: CHNO TB-500 (fragment): CHNOS Molecular Weight: BPC-157: ~1,419.5 g/mol TB-500 (fragment): ~4,963 g/mol CAS Numbers: BPC-157: 137525-51-0 TB-500: 77591-33-4 Classification: Synthetic research peptide blend (dual-component) Purity: 99 % (HPLC-verified research grade) Appearance: White to off-white lyophilized (freeze-dried) powder Intended Use: For laboratory research only not approved for human or veterinary use
Discover HealOS agents: Prior Authorization Agent Insurance Verification Agent Clinical Documentation Agent Denial Management Agent EHR Interoperability Agent Empower your practice with HealOS for streamlined workflows and improved patient outcomes.
US$ 29.69
US$ 24.27
US$ 20.85
US$ 23.80
